BMP signaling is very important in bone development; it is not surprising that variations in BMP antagonists may affect skeletogenesis and BMD variations in humans (e.g., the sclerosteosis/van Buchem disease gene, which is caused by mutations in SOST) [37]. Here, SOST is linked to sclerosteosis.